{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:05:42Z","timestamp":1781229942592,"version":"3.54.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We attempted to investigate whether vitamin K2 (menatetrenone) treatment effectively prevents the incidence of new fractures in osteoporosis. A total of 241 osteoporotic patients were enrolled in a 24-month randomized open label study. The control group (without treatment; n = 121) and the vitamin K2\u2013treated group (n = 120), which received 45 mg\/day orally vitamin K2, were followed for lumbar bone mineral density (LBMD; measured by dual-energy X-ray absorptiometry [DXA]) and occurrence of new clinical fractures. Serum level of Glu-osteocalcin (Glu-OC) and menaquinone-4 levels were measured at the end of the follow-up period. Serum level of OC and urinary excretion of deoxypyridinoline (DPD) were measured before and after the treatment. The background data of these two groups were identical. The incidence of clinical fractures during the 2 years of treatment in the control was higher than the vitamin K2\u2013treated group (\u03c72 = 10.935; p = 0.0273). The percentages of change from the initial value of LBMD at 6, 12, and 24 months after the initiation of the study were \u22121.8 \u00b1 0.6%, \u22122.4 \u00b1 0.7%, and \u22123.3 \u00b1 0.8% for the control group, and 1.4 \u00b1 0.7%, \u22120.1 \u00b1 0.6%, and \u22120.5 \u00b1 1.0% for the vitamin K2\u2013treated group, respectively. The changes in LBMD at each time point were significantly different between the control and the treated group (p = 0.0010 for 6 months, p = 0.0153 for 12 months, and p = 0.0339 for 24 months). The serum levels of Glu-OC at the end of the observation period in the control and the treated group were 3.0 \u00b1 0.3 ng\/ml and 1.6 \u00b1 0.1 ng\/ml, respectively (p &amp;lt; 0.0001), while the serum level of OC measured by the conventional radioimmunoassay (RIA) showed a significant rise (42.4 \u00b1 6.9% from the basal value) in the treated group at 24 months (18.2 \u00b1 6.1% for the controls; p = 0.0081). There was no significant change in urinary DPD excretion in the treated group. These findings suggest that vitamin K2 treatment effectively prevents the occurrence of new fractures, although the vitamin K2\u2013treated group failed to increase in LBMD. Furthermore, vitamin K2 treatment enhances \u03b3-carboxylation of the OC molecule.<\/jats:p>","DOI":"10.1359\/jbmr.2000.15.3.515","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T02:14:02Z","timestamp":1146104042000},"page":"515-521","source":"Crossref","is-referenced-by-count":318,"title":["Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis"],"prefix":"10.1093","volume":"15","author":[{"given":"Masataka","family":"Shiraki","sequence":"first","affiliation":[{"name":"Research Institute and Practice for Involutional Diseases, Nagano Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Research Institute and Practice for Involutional Diseases, Nagano Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choju","family":"Aoki","sequence":"additional","affiliation":[{"name":"Research Institute and Practice for Involutional Diseases, Nagano Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Mitsubishi Kagaku Bio-Clinical Laboratories, Inc., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,2,18]]},"reference":[{"key":"2024020714104456000_bib1","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1073\/pnas.71.7.2730","article-title":"Vitamin K dependent modification of glutamic acid residues in prothrombin","volume":"71","author":"Stenflo","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024020714104456000_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0006-291X(74)90353-2","article-title":"The vitamin K dependent, in vitro production of prothrombin","volume":"60","author":"Shah","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"2024020714104456000_bib3","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1016\/S0021-9258(20)81823-7","article-title":"Vitamin K and biosynthesis of prothrombin","volume":"247","author":"Stenflo","year":"1972","journal-title":"J Biol Chem"},{"key":"2024020714104456000_bib4","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1073\/pnas.73.10.3374","article-title":"Primary structure of the \u03b3-carboxyglutamic acid-containing protein from bovine bone","volume":"73","author":"Price","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024020714104456000_bib5","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1073\/pnas.72.10.3925","article-title":"Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue","volume":"72","author":"Hauschka","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024020714104456000_bib6","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/bi00539a038","article-title":"Calcium-dependent \u03b1-helical structure in osteocalcin","volume":"21","author":"Haushka","year":"1975","journal-title":"Biochemistry"},{"key":"2024020714104456000_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jbmr.5650080504","article-title":"Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro","volume":"8","author":"Hara","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024020714104456000_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(94)90539-8","article-title":"Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures","volume":"263","author":"Akiyama","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"2024020714104456000_bib9","first-page":"466","article-title":"Vitamin K2 promote 1,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts","volume":"59","author":"Koshihara","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"2024020714104456000_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/8756-3282(93)90309-X","article-title":"Effects of menatetrenone on predonisolone-induced bone loss in rats","volume":"14","author":"Hara","year":"1993","journal-title":"Bone"},{"key":"2024020714104456000_bib11","first-page":"145","article-title":"Effects of menatetrenone on bone loss induced by ovariectomy in rats","volume":"62","author":"Akiyama","year":"1993","journal-title":"Jpn J Pharmacol"},{"key":"2024020714104456000_bib12","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jcem-60-6-1268","article-title":"Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis","volume":"60","author":"Hart","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714104456000_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/8756-3282(91)90027-G","article-title":"Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck","volume":"12","author":"Hodges","year":"1991","journal-title":"Bone"},{"key":"2024020714104456000_bib14","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/jbmr.5650061111","article-title":"Impaired carboxylation of serum osteocalcin in elderly women","volume":"6","author":"Plantalech","year":"1991","journal-title":"J Bone Miner Res."},{"key":"2024020714104456000_bib15","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI116387","article-title":"Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women","volume":"91","author":"Szulc","year":"1993","journal-title":"J Clin Invest"},{"key":"2024020714104456000_bib16","first-page":"719","article-title":"Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS study","volume":"82","author":"Vergnaud","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714104456000_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s007740050034","article-title":"Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blinded placebo-controlled study","volume":"16","author":"Orimo","year":"1998","journal-title":"J Bone Miner Metab"},{"key":"2024020714104456000_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s007740050038","article-title":"Diagnostic criteria of primary osteoporosis","volume":"16","author":"Orimo","year":"1998","journal-title":"J Bone Miner Metab"},{"key":"2024020714104456000_bib19","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1359\/jbmr.1997.12.9.1438","article-title":"Association of bone mineral density with apolipoprotein E phenotype","volume":"12","author":"Shiraki","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714104456000_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-65-3-407","article-title":"Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay","volume":"65","author":"Brown","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714104456000_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3177\/jnsv.27.71","article-title":"Radioreceptor assay for 1 alpha 24(R), 25 trihydroxyvitamin D in human serum","volume":"27","author":"Ishizuka","year":"1981","journal-title":"J Nutr Sci Vitaminol"},{"key":"2024020714104456000_bib22","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/clinchem\/40.11.2071","article-title":"Six osteocalcin assay compared","volume":"40","author":"Diego","year":"1994","journal-title":"Clin Chem"},{"key":"2024020714104456000_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-6009(91)90143-N","article-title":"Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease","volume":"8","author":"Ubelhart","year":"1990","journal-title":"Bone Miner"},{"key":"2024020714104456000_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"2024020714104456000_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0022-3476(75)80986-3","article-title":"Congenital malformations associated with the administration of oral anticoaglants during pregnancy","volume":"86","author":"Pettifor","year":"1975","journal-title":"J Pediatr"},{"key":"2024020714104456000_bib26","first-page":"287","article-title":"A warfarin embryopathy?","volume":"129","author":"Warkany","year":"1975","journal-title":"Am J Dis Child"},{"key":"2024020714104456000_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoaglation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"Am J Med"},{"key":"2024020714104456000_bib28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","article-title":"Pre-existing fractures and bone mass predict vertebral fracture incidence in women","volume":"114","author":"Ross","year":"1991","journal-title":"Ann Intern Med"},{"key":"2024020714104456000_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","article-title":"Effect of 1\u03b1-hydroxy vitamin D3 on lumbar bone mineral density and vertebral fractures with postmenopausal osteoporosis","volume":"54","author":"Orimo","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"2024020714104456000_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1507\/endocrj.43.211","article-title":"Effects of 2 years' treatment of osteoporosis with 1\u03b1-hydroxy vitamin D3 on bone mineral density and incidence of fracture: A placebo-controlled, double-blind prospective study","volume":"43","author":"Shiraki","year":"1996","journal-title":"Endocr J"},{"key":"2024020714104456000_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/0003-4819-102-3-319","article-title":"Long-term estrogen replacement therapy prevents bone loss and fracture","volume":"102","author":"Ettinger","year":"1985","journal-title":"Ann Intern Med"},{"key":"2024020714104456000_bib32","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effects of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"2024020714104456000_bib33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fracture","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"2024020714104456000_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(05)60600-9","article-title":"Pre-emptive bone sticks in prevention of osteoporosis","volume":"351","author":"Rosen","year":"1998","journal-title":"Lancet"},{"key":"2024020714104456000_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF03347118","article-title":"Biochemical short-term changes produced by hormonal replacement therapy","volume":"14","author":"Aloia","year":"1991","journal-title":"J Endocrinol Invest"},{"key":"2024020714104456000_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-72-2-367","article-title":"Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links","volume":"72","author":"Ubelhart","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714104456000_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1507\/endocrj.45.191","article-title":"A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis","volume":"45","author":"Shiraki","year":"1998","journal-title":"Endocr J"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2000.15.3.515","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/3\/515\/56603208\/5650150315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/3\/515\/56603208\/5650150315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:00:16Z","timestamp":1710342016000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/15\/3\/515-521\/7515533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,2,18]]},"published-print":{"date-parts":[[2000,3,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2000.15.3.515","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,3,1]]},"published":{"date-parts":[[2000,3,1]]}}}